Spearhead Capital Advisors, LLC
- SEC CIK
- 0001718982
- Latest filing
- Nov 9, 2022
KNSA holding history
Kiniksa Pharmaceuticals International, plc in every 13F filed by Spearhead Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KNSA overviewAll 13F holders of KNSAFull Q3 2022 holdings
- Shares (Q3 2022)
- 202,580
- Value
- $2.60M
- % of portfolio
- 2.8%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 202,580 | $2.60M | 2.8% | −32,444−13.8% | Reduced | Holders |
| Q2 2022 | 235,024 | $2.28M | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2022 | 235,024 | $2.34M | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2021 | 235,024 | $2.77M | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2021 | 235,024 | $2.68M | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2021 | 235,024 | $3.27M | 0.4% | −141,821−37.6% | Reduced | Holders |
| Q1 2021 | 376,845 | $6.97M | 1.0% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.